Back to jobs
New

Scientist I/II, Therapeutic Technologies

South San Francisco, California, United States

Scientist I/II, Therapeutic Technologies - GPCR Pharmacology & Metabolic disease | South San Francisco, CA |  Full-Time

Company
Addition Therapeutics is at the forefront of biotechnology innovation and is building the next generation of gene therapy using our proprietary PRINT™ (Programmable RNA-guided Integration Technology) platform. PRINT™ redefines genetic medicine by enabling development of RNA-only therapeutics capable of inserting any genetic element into specific safe harbor sites within the genome. Operating from state-of-the-art labs in South San Francisco, we are a Series A-stage company with programs across rare and common diseases.

The Role
We are looking for a Scientist I or II to join our Therapeutic Technologies team, focused on GPCR pharmacology and disease assay development. This is a hands-on research role: you’ll build the cell-based and in vivo assays that evaluate PRINT-delivered payloads in disease-relevant contexts, from early discovery through IND-enabling studies.

The ideal candidate has deep experience in GPCR biology - receptor signaling, ligand pharmacology, internalization, and the downstream functional consequences of receptor activation. You know how to translate that expertise into rigorous assays that answer real therapeutic questions. Familiarity with cardiometabolic-disease-relevant GPCRs. You’ll work closely with our RNA sciences and protein engineering teams to define program-specific success metrics and help us achieve them.

About the Role
The day-to-day responsibilities of this role will include:

  • Design, develop, and validate cell-based pharmacology assays for GPCR targets - including cAMP, beta-arrestin recruitment, receptor internalization, and pathway-selective (biased agonism) readouts that can differentiate construct performance across the combinatorial screening space.
  • Apply deep mechanistic fluency in GPCR pharmacology to guide candidate prioritization, model selection, and assay design. Inform interpretation of in vivo results based on mechanistic insights generated from in vitro pharmacology studies
  • Execute in vitro assays using primary cells and disease-relevant cell lines to characterize PRINT-delivered payload activity, including where applicable adipocytes, hepatocytes, pancreatic, and neuronal models.
  • Support in vivo studies in rodent disease models, including study design and pharmacodynamic endpoint analysis.
  • Apply quantitative molecular techniques (ddPCR, qPCR, ELISA, Western blot, flow cytometry) to characterize transgene expression, protein secretion, and PD endpoints.
  • Work with HTS infrastructure and liquid handling automation to scale assay throughput as programs expand
  • Collaborate with computational biology and protein engineering colleagues to close the loop between payload design and functional readout.
  • Contribute to data packages supporting IND-enabling studies, partnership diligence, and investor milestones.

What We’re Looking For

Required

  • D. in biochemistry, pharmacology, cell biology, or a closely related field (relevant industry experience considered in lieu of Ph.D.)
  • Hands-on experience with GPCR pharmacology assays -receptor signaling, internalization, cAMP/arrestin assays, or similar
  • Strong cell culture skills: primary cells or iPSC-derived models
  • Proficiency across standard molecular/biochemical assay platforms: ELISA, ddPCR, qPCR, Western blot, flow cytometry
  • Ability to independently design experiments, troubleshoot, and interpret data with minimal hand-holding
  • Clear, organized scientific communicator, comfortable presenting data to cross-functional audiences

Preferred

  • Experience with obesity- or metabolic-disease-relevant GPCRs and the pharmacology of incretin-class or other anti-obesity therapeutics
  • Familiarity with metabolic phenotyping endpoints (body composition, energy expenditure, glucose/insulin tolerance, lipid profiling) and disease-relevant tissue biology (adipose, liver, gut, hypothalamus)
  • Experience with secreted protein biology or hormone pharmacology in a disease context
  • Familiarity with HTS or automated liquid handling platforms
  • Experience with gene therapy, mRNA, or RNA-based therapeutic modalities
  • Exposure to NHP or translational PK/PD study design

Why Addition

    • You’ll be an early scientific contributor to a program with real momentum -novel biology, a differentiated platform, and partnerships that validate the direction.
    • Small team, high autonomy. Your assays will directly inform program decisions, not sit in a queue.
    • Work at the intersection of cutting-edge gene therapy and high-value disease biology.
    • Competitive salary, equity, and benefits. South San Francisco location with a collaborative, no-nonsense lab culture.

Compensation 

The expected annual salary range for this full-time position is $121,000 - $152,000  plus eligibility for bonus, benefits, and equity incentives. Actual pay will be determined based on experience, qualifications, business needs, internal equity, and alignment with market data.

We are an Equal Opportunity employer and will consider all qualified applicants for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, or disability status.

 

Create a Job Alert

Interested in building your career at Addition Therapeutics? Get future opportunities sent straight to your email.

Apply for this job

*

indicates a required field

Resume/CV*

Accepted file types: pdf, doc, docx, txt, rtf

Cover Letter

Accepted file types: pdf, doc, docx, txt, rtf

Education

Select...
Select...
Select...
Select...

(Proof of identity and eligibility will be required upon employment)

Select...
Select...

(If no, you may be required to provide authorization to work.)

Select...

[Please answer only if you have worked at Addition Therapeutics in the past]

[Please answer only if you have worked at Addition Therapeutics in the past]

[Please answer only if you have worked at Addition Therapeutics in the past]

Select...
Select...

Voluntary Self-Identification

For government reporting purposes, we ask candidates to respond to the below self-identification survey. Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiring process or thereafter. Any information that you do provide will be recorded and maintained in a confidential file.

As set forth in Addition Therapeutics’s Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law.

Select...
Select...
Race & Ethnicity Definitions

If you believe you belong to any of the categories of protected veterans listed below, please indicate by making the appropriate selection. As a government contractor subject to the Vietnam Era Veterans Readjustment Assistance Act (VEVRAA), we request this information in order to measure the effectiveness of the outreach and positive recruitment efforts we undertake pursuant to VEVRAA. Classification of protected categories is as follows:

A "disabled veteran" is one of the following: a veteran of the U.S. military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or a person who was discharged or released from active duty because of a service-connected disability.

A "recently separated veteran" means any veteran during the three-year period beginning on the date of such veteran's discharge or release from active duty in the U.S. military, ground, naval, or air service.

An "active duty wartime or campaign badge veteran" means a veteran who served on active duty in the U.S. military, ground, naval or air service during a war, or in a campaign or expedition for which a campaign badge has been authorized under the laws administered by the Department of Defense.

An "Armed forces service medal veteran" means a veteran who, while serving on active duty in the U.S. military, ground, naval or air service, participated in a United States military operation for which an Armed Forces service medal was awarded pursuant to Executive Order 12985.

Select...

Voluntary Self-Identification of Disability

Form CC-305
Page 1 of 1
OMB Control Number 1250-0005
Expires 04/30/2026

Why are you being asked to complete this form?

We are a federal contractor or subcontractor. The law requires us to provide equal employment opportunity to qualified people with disabilities. We have a goal of having at least 7% of our workers as people with disabilities. The law says we must measure our progress towards this goal. To do this, we must ask applicants and employees if they have a disability or have ever had one. People can become disabled, so we need to ask this question at least every five years.

Completing this form is voluntary, and we hope that you will choose to do so. Your answer is confidential. No one who makes hiring decisions will see it. Your decision to complete the form and your answer will not harm you in any way. If you want to learn more about the law or this form, visit the U.S. Department of Labor’s Office of Federal Contract Compliance Programs (OFCCP) website at www.dol.gov/ofccp.

How do you know if you have a disability?

A disability is a condition that substantially limits one or more of your “major life activities.” If you have or have ever had such a condition, you are a person with a disability. Disabilities include, but are not limited to:

  • Alcohol or other substance use disorder (not currently using drugs illegally)
  • Autoimmune disorder, for example, lupus, fibromyalgia, rheumatoid arthritis, HIV/AIDS
  • Blind or low vision
  • Cancer (past or present)
  • Cardiovascular or heart disease
  • Celiac disease
  • Cerebral palsy
  • Deaf or serious difficulty hearing
  • Diabetes
  • Disfigurement, for example, disfigurement caused by burns, wounds, accidents, or congenital disorders
  • Epilepsy or other seizure disorder
  • Gastrointestinal disorders, for example, Crohn's Disease, irritable bowel syndrome
  • Intellectual or developmental disability
  • Mental health conditions, for example, depression, bipolar disorder, anxiety disorder, schizophrenia, PTSD
  • Missing limbs or partially missing limbs
  • Mobility impairment, benefiting from the use of a wheelchair, scooter, walker, leg brace(s) and/or other supports
  • Nervous system condition, for example, migraine headaches, Parkinson’s disease, multiple sclerosis (MS)
  • Neurodivergence, for example, attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder, dyslexia, dyspraxia, other learning disabilities
  • Partial or complete paralysis (any cause)
  • Pulmonary or respiratory conditions, for example, tuberculosis, asthma, emphysema
  • Short stature (dwarfism)
  • Traumatic brain injury
Select...

PUBLIC BURDEN STATEMENT: According to the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless such collection displays a valid OMB control number. This survey should take about 5 minutes to complete.